Sugi Predict

Sugi Predict / Compounds / SCHEMBL5704663

SCHEMBL5704663

SCHEMBL5704663

CCCCCCC(=O)OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 8/20 0.43
▸ CES1 P23141 5/20 0.43
▸ CES2 O00748 2/20 0.43
▸ DGKA P23743 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ LMNA P02545 2/20 0.41
▸ PAM P19021 2/20 0.40
▸ MAPT P10636 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11404272 1.00 FAAH (0.43) FAAHCES1CES2DGKAMEN1
SCHEMBL3796037 1.00 FAAH (0.43) FAAHCES1CES2DGKAMEN1
SCHEMBL11398178 1.00 FAAH (0.43) FAAHCES1CES2DGKAMEN1
SCHEMBL1405538 0.98 FAAH (0.42) FAAHCES1CES2DGKAMEN1
SCHEMBL28541118 0.94 FAAH (0.46) FAAHCES1CES2DGKAMEN1
SCHEMBL1405156 0.92 ALDH1A1 (0.38) FAAHCES1CES2DGKAMEN1
SCHEMBL11292471 0.92 FAAH (0.44) FAAHCES1CES2DGKAMEN1
SCHEMBL9615326 0.92 FAAH (0.51) FAAHCES1MEN1CYP1A2KMT2A
Octane SCHEMBL6156021 0.89 THRB (0.42) FAAHCES1CES2MEN1CYP1A2
SCHEMBL11292687 0.87 FAAH (0.48) FAAHCES1CES2DGKAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111848832-B Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof 苏州大学 2024-02-20 — — CN claimed
CN-111892667-B Application of fluorine-containing compound modified cationic polymer in preparation of medical cosmetic and health care products 苏州大学 2024-02-20 — — CN claimed
CN-116845345-A Preparation method of gel quasi-solid electrolyte, gel quasi-solid electrolyte and lithium ion battery 阜新德尔汽车部件股份有限公司 2023-10-03 — — CN claimed
CN-111848831-B Application of fluorine-containing compound modified cationic polymer in preparation of vaccine medicine 苏州大学 2023-06-13 — — CN claimed
EP-4095162-A1 APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER Soochow University (CN) 2022-11-30 — — EP claimed
US-20220273806-A1 USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD SOOCHOW UNIVERSITY (CN) 2022-09-01 — — US claimed
WO-2021147585-A1 USE OF CHITOSAN MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER AND PREPARATION METHOD THEREFOR 苏州大学 2021-07-29 — — WO claimed
WO-2021147598-A1 APPLICATION OF AND PREPARATION METHOD FOR CATIONIC POLYMER MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER 苏州大学 2021-07-29 — — WO claimed
CN-111892667-A Application of cationic polymer modified by fluorine-containing compound in preparation of medical beauty and health care products 苏州大学 2020-11-06 — — CN claimed
CN-111848832-A Application of fluorine-containing compound modified cationic polymer as drug carrier and preparation method thereof 苏州大学 2020-10-30 — — CN claimed
CN-111848831-A Application of fluorine-containing compound modified cationic polymer in preparation of vaccine drugs 苏州大学 2020-10-30 — — CN claimed
CN-111848830-A Application of fluorine-containing compound modified chitosan as drug carrier and preparation method thereof 苏州大学 2020-10-30 — — CN claimed
US-20200203711-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES ENEVATE CORPORATION 2020-06-25 — — US claimed
WO-2020132057-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES ENEVATE CORPORATION (US) 2020-06-25 — — WO claimed
EP-1303258-B1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE ASTRAZENECA AB (SE) 2006-10-11 — — EP claimed
US-20030194378-A1 Novel aerosol formulation containing a polar fluorinated molecule ASTRAZENECA AB (SE) 2003-10-16 — — US claimed
EP-1303258-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE AstraZeneca AB (SE) 2003-04-23 — — EP claimed
WO-2002003958-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE ASTRAZENECA AB (SE) 2002-01-17 — — WO claimed
EP-3635022-B1 METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME ETNA TEC LTD (US) 2025-05-21 — — EP disclosed
US-4255594-A Hydrogenation of halogen-containing carboxylic anhydrides ALLIED CHEMICAL CORPORATION (US) 1981-03-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220273806-A1 USE OF FLUORINE-CONTAINING COMPOUND-MODIFIED CATIONIC POLYMER AS DRUG CARRIER AND PREPARATION METHOD F12, SLCO4C1, SLC7A1 FAAH 407/4885CES1 204/4885CES2 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.